Truist Financial Reaffirms Their Buy Rating on Incyte (INCY)
TipRanksApr 29 07:53 ET
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Yahoo FinanceApr 26 08:25 ET
Incyte's Strategic Acquisition and Promising Pipeline Secure Buy Rating
TipRanksApr 26 02:16 ET
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates From VRTX
Yahoo FinanceApr 25 14:28 ET
Express News | Incyte : Oppenheimer Cuts Target Price to $84 From $92
Moomoo 24/7Apr 24 08:03 ET
Oppenheimer Sticks to Its Buy Rating for Incyte (INCY)
TipRanksApr 24 07:46 ET
Incyte Price Target Cut to $84.00/Share From $92.00 by Oppenheimer
Incyte Price Target Cut to $84.00/Share From $92.00 by Oppenheimer
Dow JonesApr 24 07:33 ET
Incyte Is Maintained at Outperform by Oppenheimer
Incyte Is Maintained at Outperform by Oppenheimer
Dow JonesApr 24 07:33 ET
Express News | Oppenheimer Maintains Outperform on Incyte, Lowers Price Target to $84
Moomoo 24/7Apr 24 07:22 ET
Truist Financial Keeps Their Buy Rating on Incyte (INCY)
TipRanksApr 24 07:18 ET
Incyte Acquisition Strategy and Drug Pipeline Evaluation: A Hold Recommendation
TipRanksApr 24 05:35 ET
Express News | Incyte Corp : Oppenheimer Cuts Target Price to $84 From $93
Moomoo 24/7Apr 23 23:29 ET
Incyte's Strategic Acquisition: A Premature and Costly Move Amid Patent Cliff Concerns
TipRanksApr 23 19:05 ET
Incyte (INCY) Gets a Buy From Piper Sandler
TipRanksApr 23 15:25 ET
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
Tuesday, Incyte Corporation (NASDAQ:INCY) agreed to acquire Escient Pharmaceuticals for $750 million.Escient's pipeline includes EP262, a small molecule antagonist of Mas-related G protein-coupled rec
BenzingaApr 23 15:03 ET
Peeling Back The Layers: Exploring Incyte Through Analyst Insights
Across the recent three months, 10 analysts have shared their insights on Incyte (NASDAQ:INCY), expressing a variety of opinions spanning from bullish to bearish.The table below provides a concise ove
BenzingaApr 23 13:01 ET
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
Yahoo FinanceApr 23 10:01 ET
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Yahoo FinanceApr 23 09:44 ET
Incyte To Buy Privately Held Escient Pharma
RTTNewsApr 23 08:14 ET
Incyte Initiated at Neutral by Cantor Fitzgerald
Incyte Initiated at Neutral by Cantor Fitzgerald
Dow JonesApr 23 08:10 ET
No Data
No Data